The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
We focus on a number of topic areas identified by state health policy leaders as important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports and issues briefs on topics important to population health.
September 2009 (Volume 87)
September 2009 | Michelle M. Mello, Lawrence O. Gostin
The New York City A1C Registry (NYCAR) program is an unusual and groundbreaking extension of the reach of public health law. It marks the first time that the government has mandated name-based reporting of a chronic, noninfectious disease not caused by an environmental toxin and where the data are given to patients and physicians. Although the program has generated deep social controversy, remarkably it has not been challenged in court. Nonetheless, the law offers a useful lens through which to consider the program’s justification and legitimacy. In this commentary to the article in this issue by Chamany and colleagues (2009), we examine the state’s powers and responsibilities; patients’ rights to privacy and security of personal data; and physicians’ “privacy” rights.
Author(s): Michelle M. Mello; Lawrence O. Gostin
Read on Wiley Online Library
Read on JSTOR
Volume 87, Issue 3 (pages 575–580) DOI: 10.1111/j.1468-0009.2009.00570.x Published in 2009
Previous article
Commentary: Public Health and Health Care Quality Assurance—Strange Bedfellows?
Next article
Commentary: Beyond Historical Precedent
